Method for the treatment of Streptococcus pneumoniae infection

Details Method for the treatment of Streptococcus pneumoniae infection Method for the treatment of Streptococcus pneumoniae infection

1996-12-20

1999-06-08

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 13, A61K 3816

Patent

active

059104791

ABSTRACT:
The invention concerns methods for killing antibiotic-resistant pathogenic bacteria which cause disease in humans and animals. In particular, the methods are directed to the killing of antibiotic-resistant or multi-drug resistant Streptococcus pneumoniae bacterial strains. The methods employ a lanthocin such as nisin or a variant thereof as bactericidal agent.

REFERENCES:
patent: 4548924 (1985-10-01), Michel
patent: 4931390 (1990-06-01), Recsei
patent: 4980163 (1990-12-01), Blackburn et al.
patent: 5112806 (1992-05-01), Chatterjee et al.
patent: 5217950 (1993-06-01), Blackburn et al.
patent: 5231013 (1993-07-01), Jung et al.
patent: 5260271 (1993-11-01), Blackburn et al.
patent: 5310900 (1994-05-01), Barriere et al.
patent: 5334582 (1994-08-01), Blackburn et al.
patent: 5512269 (1996-04-01), Molina y Vedia
patent: 5637565 (1997-06-01), Anger et al.
patent: 5650320 (1997-07-01), Caufield et al.
Bottone et al, Characteristics of a Bacteriocin Derived from . . . Applied Microbiology. vol. 22, No. 2, pp. 200-204, Aug. 1971.
Niu, et al., Antimicrob. Agents Chemother. 35: 998-1000 (1991).
Chatterjee, et al., J. Antibiot. (Japan) 45(6): 839-845 (1992).
Reisinger, et al., Arch. Microbiol. 127: 187-198 (1992).
Bierbaum et al. Cloning, Sequencing, and production of . . . FEMS Microbiology Lett. vol. 127, pp. 121-126, 1995.
Malabarba et al. Synthesis and Biological Activity of . . . J. Antibiotics, vol. XLIII, No. 9, pp. 1089-1097, Sep. 1990.
Brotz et al. The Lantibiotic mersacidin inhibits . . . Eur. J. Biochem. vol. 246, pp. 193-199, 1997.
Brotz et al. The lantibiotic mersacidin inhibits . . . Antimicrob. Agents Chemotherapy. vol. 42, No. 1, pp. 154-160, Jan. 1998.
Sahl et al. Biosynthesis and biological activities . . . Eur. J. Biochem. vol. 230, pp. 827-853, 1995.
Orberg, et al., Applied Environ. Microbiol. 49:538-542 (1985).
Brotz, et al., Antimicrob. Agents Chemotherapy 39(3): 714-719, (1995).
Barrett, et al., Diagn. Microbiol. Infect. Dis. 15(7): 641-644, (1992).
Murray, B.E., Clin. Micorbiol. Rev. 3(1): 46-65 (1990).
"Invasive Group A Streptococcal Infections --United Kingdom, 1994" MMWR, pp. 401-402 (1994).
Bavin, et al., Lancet 1:127-129 (1952).
Gowans, et al., Brit. J. Pharmacol. 7:438-449 (1952).
Szybalski, W., Dept. Health and Human Services, FDA Fed. Regis. 53 (66): pp. 1095-1103 (1988).
Hirsch, et al., Lancet ii:190-193 (1949).
Mattick, et al., Lancet 2:5-8 (1947).
Somma, et al., Antimicrob. Ag. Chemother. 11:396-401 (1977).
Arioli, et al., J. Antibiot. 29:511-515 (1976).
Karchmer, A.W., Ann. Int. Med. 115(9):739-741 (1991).
Jung, "Nisin and Novel Lantibiotics," ESCOM Science Publishers, Leiden, pp. 1-34 (1991).
Emori, et al., Clin. Microbiol. Rev. 6(4):428-442 (1993).
Ramseier, H.R., Archiv. fur Mikrobiol. 37:57-94 (1960).
Hossack, et al., Federal Register, vol. 53, No. 668, pp. 1-30, Apr. 6, 1988.
Stutman, H.R., Infections in Medicine 10: Suppl. D.:51-55 (1993).
Thornsberry, et al., Infections in Medicine 10 Suppl. D.: 15-24 (1993).
Noble, et al., FEMS Microbiol. Lett. 72:195-198 (1992).

Affiliated with

Also associated with

Rating

Method for the treatment of Streptococcus pneumoniae infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of Streptococcus pneumoniae infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of Streptococcus pneumoniae infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1683313